GERD (acid reflux) decisions — 2025

The Board remands the claims for initial compensable ratings for a left finger fracture, GERD, migraines, and urinary frequency due to the VA's failure to assist by rescheduling the Veteran for VA examinations after his address was updated.

The Board remands the claims for a new VA examination to address all symptomology and obtain relevant records from Vista Imaging.

The Board denied an initial rating in excess of 10 percent for gastroesophageal reflux disease (GERD) as the Veteran's symptoms did not more nearly approximate those productive of considerable impairment of health.

The Board denied service connection for GERD, shortness of breath, an initial compensable disability rating for allergic rhinitis, and an initial compensable disability rating for smallpox scar. The acne claim was remanded.

The Board granted the restoration of a 60 percent rating for GERD, effective July 29, 2016.

The Veteran's service connection for asthma was denied, but a total disability rating based on individual unemployability (TDIU) from October 11, 2017 was granted.

The Board denied the veteran's claims for increased ratings for gastroesophageal reflux disease, erectile dysfunction, and neurogenic bladder.

The Veteran's GERD was granted an initial rating of 60 percent from May 6, 2021, to August 11, 2023.

The Board granted a 10 percent rating for the residuals of right ring finger mid-metacarpal fracture remodeling surgery based on painful motion of the wrist from July 6, 2021, to June 14, 2022, and denied a higher rating since June 15, 2022. The Board also granted a separate 10 percent rating for painful motion of the right long finger since July 6, 2021.

The Board granted service connection for gastroesophageal reflux disease (GERD) as secondary to the Veteran's service-connected depressive disorder.

The Board granted an initial disability rating of 60 percent for the Veteran's service-connected gastroesophageal reflux disease, finding that the symptoms more nearly approximated severe impairment of health.

The Board granted service connection for arteriosclerotic heart disease, resolving reasonable doubt in favor of the Veteran. The issues of entitlement to service connection for hypertension and GERD were remanded.

The Board granted an initial 60 percent rating for gastroesophageal reflux disease (GERD) based on the severity of symptoms including pain and vomiting, which more nearly approximated the criteria required for a 60 percent evaluation.

The Board remands the claims for service connection for sleep apnea and GERD due to a pre-decisional duty to assist error, specifically regarding potential exposure to chemical warfare agents and PCBs.

The Board remands the Veteran's claim for service connection for GERD to correct a pre-decisional duty to assist error, as the December 2023 examination was found inadequate.

The Board denied the Veteran's appeal for an initial disability rating in excess of 30 percent for his service-connected GERD, as the evidence did not support a higher rating.

The Board denied service connection for type II diabetes, peripheral neuropathy of the bilateral upper and lower extremities, GERD, liver cancer, heart disability, skin cancer, sinusitis, and a heart disability on the basis that there was no evidence to support an in-service incurrence or continuity of symptomatology since service.

The Board granted eligibility for the direct payment of attorney fees based on 20 percent of past due benefits awarded in a May 2023 rating decision, but denied entitlement to additional fees.

The Board granted service connection for gastroesophageal reflux disease and chronic epididymitis, but remanded the claim for motion sickness due to missing service treatment records.

The Board denied service connection for multiple conditions, including a right elbow disability, digestive disorder other than GERD, dizziness/vertigo disorder, STD, skin disorders of the toes and face, ears, neck, and jawline.